Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: drug utilization and patient characteristics.
Saved in:
| Title: | Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: drug utilization and patient characteristics. |
|---|---|
| Authors: | Bruno GM; Centro di Ricerca, S.A.V.E. Studi Analisi Valutazioni Economiche, Milan - Italy., Valentino MC; Centro di Ricerca, S.A.V.E. Studi Analisi Valutazioni Economiche, Milan - Italy., Buda S; Centro di Ricerca, S.A.V.E. Studi Analisi Valutazioni Economiche, Milan - Italy., Paciello A; Servizio Farmaceutico Territoriale ATS Bergamo, Bergamo - Italy., Palcic S; Azienda Sanitaria Universitaria Giuliano Isontina - ASUGI, Trieste - Italy., Colombo GL; Centro di Ricerca, S.A.V.E. Studi Analisi Valutazioni Economiche, Milan - Italy. |
| Source: | Global & regional health technology assessment [Glob Reg Health Technol Assess] 2026 Jun 26; Vol. 13, pp. 167-176. Date of Electronic Publication: 2026 Jun 26 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: AboutScience Country of Publication: Italy NLM ID: 9918417986506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2283-5733 (Electronic) Linking ISSN: 22842403 NLM ISO Abbreviation: Glob Reg Health Technol Assess Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2283-5733 |
|---|---|
| DOI: | 10.33393/grhta.2026.3790 |
